sharecast

{{ storiesRelated.title }}

International Companies
29 Jan
coronavirus-plus-de-138-000-personnes-vaccinees-en-france
Novartis inks deal to help Pfizer-BioNTech ramp up output of Covid-19 vaccine

Switzerland's Novartis AG has inked a deal with Pfizer-BioNTech aimed at boosting the world's output of Covid-19 vaccines.

29 Jan
sec securities exchange commision
US SEC warns market participants to follow rules, warns on volatility

America's stockmarket regulator warned of the possible fallout from the recent sharp volatility in the share prices of smaller firms.

29 Jan
ep facebook 20200417104903
Facebook to develop tools for advertisers to remove harmful content

Facebook said Friday it would develop “topic exclusion controls” on its platform to give advertisers tools to remove harmful content that appears alongside their ads.

29 Jan
ubercbautomatico
CMA launches inquiry into Uber's Autocab acquisition

Uber’s acquisition of Autocab is the subject of the new inquiry by the UK’s competition watchdog that was launched on Friday.

29 Jan
johnson and johnson
Johnson and Johnson Covid-19 vaccine 85% effective against severe illness

Drugmaker Johnson & Johnson reported topline efficacy and safety data from a Phase three clinical trial on its single-dose Covid-19 vaccine on Friday, stating the drug had met all primary and key secondary endpoints.

29 Jan
tienda gamestop
Facebook shuts Robinhood Stock Traders group amid Wall Street chaos

Facebook closed down a Wall Street discussion group on its platform, Robinhood Stock Traders, amid the frenzy around GameStop shares on Wall Street.

29 Jan
meeting, takeover, talks, bid, merger, acquisition, board
Power management company Eaton to buy Tripp Lite for $1.65bn

US power management company Eaton has agreed to buy Tripp Lite, a supplier of power quality products and connectivity solutions, for $1. 65bn.

29 Jan
coronavirus-le-vaccin-de-novavax-en-2e-phase-de-test-en-afrique-du-sud 20200910130110
Novavax Covid-19 vaccine nearly 90 per cent effective, less so in South Africa

Novavax's Covid-19 vaccine candidate achieved a very high efficacy, the results of the company's late-stage clinical trials showed.